Impact of COVID-19 on Healthcare BPO Market to Show Tremendous Growth by 2027 | Leading Players-Accenture, Cognizant, GeBBS Healthcare Solutions, United Health Group, Firstsource, Charles River, Genpact - Jewish Life News
| Posted: 09 Jun 2020 12:00 AM PDT The Healthcare BPO Market study with 100+ market data Tables, Pie Chat, Graphs & Figures is now released by Data Bridge Market Research. The report presents a complete assessment of the Market covering future trend, current growth factors, attentive opinions, facts, and industry validated market data forecast till 2026. Delivering the key insights pertaining to this industry, the report provides an in-depth analysis of the latest trends, present and future business scenario, market size and share of Major Players such as Accenture, Cognizant, GeBBS Healthcare Solutions, United Health Group, Firstsource, Charles River, Genpact, Invensis Technologies Pvt Ltd Healthcare business process outsourcing (Healthcare BPO) is a specialist process vendor or technology, which manages the critical and non-critical enterprise and application of an organization. Healthcare BPO services are distinguished are based on the payers and providers. North America healthcare BPO market is expected to register a healthy CAGR of 11.0% in the forecast period of 2019 to 2026. Get Sample Report + All Related Graphs & Charts @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=north-america-healthcare-bpo-market The payers services include in managing the product development, business acquisitions, provides management, member management, care management, claim management services. The healthcare business process services for the providers and payers enhances the efficiencies, reduces cost, increases outcomes, reduces risk, deliver competitive services and cost effective. Healthcare outsourcing is an important part of the organization to reduce the cost by providing efficient healthcare services. The healthcare BPO services help vendors to minimize the administrative cost, minimizes the cost in delivering the healthcare, electronic medical records management, consumer engagement and clinical transformation. Also, the healthcare outsourcing helps and minimizes the error occurs in the medical billing, enable access to specialist, minimizes staff training cost. North America Healthcare BPO Market By Component (Payer Services, Provider Services, Pharmaceutical Services), End User (Hospital, Dental Clinics, Public Services, Life Sciences Companies, Medical Devices Companies, Pharmacy Benefit Managers, Others), Geography (U.S., Canada, Mexico) – Industry Trends and Forecast to 2026
Segmentation: North America Healthcare BPO Market North America healthcare BPO market is segmented into three notable segments such as component, end user and geography On the basis of component, the market is segmented into payer services, provider services and pharmaceutical services. The payer segment is further segmented into integrated front end and back office operations, provider management, billing and accounts management, human resource management, claims management, customer relationship management, operational/administrative management, product development and care management. The provider segment is further segmented into medical billing, medical coding, medical transcription, finance and accounts, patient enrollment and strategic planning, device monitoring, revenue cycle management. The pharmaceutical services segment is further segmented as manufacturing outsourcing, pharmacovigilance services, clinical data management, research and development, non-clinical services, sales and marketing, supply chain management and logistics, other non-clinical functions and others. In 2019, provider services segment is growing at the highest CAGR and expected to reach USD in the forecast period of 2019 to 2026. In January 2019, Charles River Laboratories entered into strategic alliance with Atomwise (U.S.). This provides clients an access to artificial intelligence-powered and drug design technology. Competitive Analysis: North America Healthcare BPO Market Some of the prominent participants operating in this market are Accenture, Cognizant, GeBBS Healthcare Solutions, United Health Group, Firstsource, Charles River, Genpact, Invensis Technologies Pvt Ltd, HCL Technologies Limited, Iqvia, WNS (HOLDINGS) LTD, Pharmaceutical Product Development, LLC., Parexel, Catalent, INC, Lonza, Covance INC., Sutherland Global, INC., Premier BPO, INC., HGS LTD.,Boehringer Ingelheim. Services Launch: In 2019, In January, Accenture launched human-machine operating engine SynOps. SynOps comprises of talent, capabilities and technology to achieve efficiency. This will help the company to become more flexible and generate more operations quickly. In 2017, Lonza launched XS Pichia 2.0 Expression and Manufacturing Platform for the formulation and development of next generation therapeutics. Drivers: North America Healthcare BPO Market Regulatory Changes in the US Regulatory norms in the U.S. health-care system are imposed by private and public entities at the federal, state and country levels. These reforms are introduced as there is a constant need of enhancing quality, expanding access, and controlling costs in healthcare. Some of the major federal regulatory organizations under the umbrella of the United States Department of Health & Human Services (HHS) include: Centers for Medicare and Medicaid Services (CMS) Pressure to Reduce Rising Healthcare Costs: The United States has the highest healthcare cost when compared with other nations. In 2016, the nation spent about $3.3 trillion on healthcare. Healthcare costs have increased drastically over the past few years in U.S. It used to be 5% GDP in 1960 which rose to 18% in 2016. The CMS projects that this trend will only rise and will reach about $5.7 trillion by 2026. Grab Your Report at an Impressive 30% Discount! Please click Here @https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=north-america-healthcare-bpo-market Restraint:North America Healthcare BPO Market Hidden Costs of Outsourcing: Outsourcing is a common practice used by many businesses in order to gain expertise in a particular geography, improve performance and to provide a greater level of service to their customers that could not be achieved with internal management. However, in recent years the shift to outsourcing has included complete outsourcing of coding and medical records, dietary services and housekeeping. In fact, nowadays services such as ER Services, Imaging, Lab, Nursing, Supply Chain, Human Resources or even Administration are outsourced by various U.S. leading hospitals. Fear of Losing Visibility and Control Over the Business Process: One of the biggest restraints in the future growth of outsourcing market is the loss of visibility and control of your own business. Loss of control in outsourcing can mean very high costs with a sub-par product that was developed behind schedule. Many a times management fear that transferring the back-office finance & administration to an outsourced provider is equal to transfer control. OPPORTUNITIES: Big Data Analytics in Healthcare Data science plays an important role in many industries. In facing massive amounts of heterogeneous data, scalable machine learning and data mining algorithms and systems have become extremely important for data scientists. The growth of volume, complexity and speed in data, drives the need for scalable data analytic algorithms and systems. The rapidly expanding field of big data analytics has started to play a pivotal role in the evolution of healthcare practices and research. It has provided tools to accumulate, manage, analyse, and assimilate large volumes of disparate, structured, and unstructured data produced by current healthcare systems. For More Insights Get Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=north-america-healthcare-bpo-market Shift to ICD-10 Coding Standards and Upcoming ICD-11 World Health Organisation (WHO) International Statistical Classification of Diseases and Related Health Problems (ICD) is a protocol while translating diagnoses and other health related problems in patient's medical record. The classification of diagnoses using ICD-10 is a mandatory national requirement for the NHS Admitted Patient Care (APC). ICD-10-CM is a seven-character, alphanumeric code in healthcare. Each code begins with a letter, followed by two numbers. The first three characters of ICD-10-CM are the category. The category describes the general type of the injury or disease. The category is followed by a decimal point and the subcategory. This is followed by up to two sub classifications, which further explain the cause, manifestation, location, severity, and type of injury or disease. The last character is the extension, which means encounter. Few examples from ICD-10 Coding Systems A00-B99 – Infectious and Parasitic Diseases CHALLENGES: Dearth of Skilled Workforce The healthcare business processing outsourcing (BPO) industry is a blooming industry but it faces a certain challenge which is hard to overcome. Healthcare BPO often require skilled labour like a person who is trained in medical coding or a person trained as medical scriber. This person should have in depth knowledge of medical terminologies. However, there are limited trained staffs for Healthcare BPOs. Also they are often unable to keep up with the field's ever growing demands. Market Trends: On the basis of component, themarket is segmented into payer services, provider services and pharmaceutical services. The payer segment is further segmented into integrated front end and back office operations, provider management, billing and accounts management, human resource management, claims management, customer relationship management, operational/administrative management, product development and care management. The provider segment is further segmented into medical billing, medical coding, medical transcription, finance and accounts, patient enrollment and strategic planning, device monitoring, revenue cycle management. The pharmaceutical services segment is further segmented as manufacturing outsourcing, pharmacovigilance services, clinical data management, research and development, non-clinical services, sales and marketing, supply chain management and logistics, other non-clinical functions and others. In 2019, provider services segment is growing at the highest CAGR and expected to reach USD in the forecast period of 2019 to 2026. On the basis of end user, the market is segmented into hospitals, dental clinics, public services, life sciences companies, medical devices companies, pharmacy benefit managers and others. In 2019, hospital segment is growing at the highest CAGR and expected to reach USD in the forecast period of 2019 to 2026. Contact: US: +1 888 387 2818 UK: +44 208 089 1725 Hong Kong: +852 8192 7475 About Data Bridge Market Research: An absolute way to forecast what future holds is to comprehend the trend today!  |
| Pathogens in food – why foodborne parasites are relevant too - New Food Posted: 16 Aug 2019 12:00 AM PDT In the summer of 2018 2,299 laboratory-confirmed cases of cyclosporiasis in the US were reported to the Centers for Disease Control and Prevention, with at least 160 people hospitalised. Professor Lucy Robertson, Chair of a COST Action on foodborne parasites, along with Working Group leaders from the Action, explains why foodborne parasites are important – and why they remain the neglected pathogens, despite their significant impact.  The increased incidence of cyclosporiasis in the US last year was not a one-off event. In 2017 there were 1,065 laboratory-confirmed cases in the US, with 384 being reported in 2016, and 546 reported in 2015. In 2014 there were 304 cases, while 2013 was another big year, with 631. Although the infection sources are often not identified, many cases have been associated with fresh produce, including imported coriander, pre-packaged vegetable trays, mixed salads from a well-known fast-food chain, basil, and various other fresh produce. This particular foodborne parasite (FBP) seems to return to US consumers on an annual basis; but why does this happen and how can we prevent it happening again? Other foodborne parasites making a splash during 2018 In addition to cyclosporiasis bothering US-based consumers in 2018, other foodborne parasitic diseases affected consumer health last year. In Santa Maria, Brazil, an outbreak of toxoplasmosis occurred. Over 800 cases had been registered by October 2018, including 114 in pregnant women and three foetal deaths. Another parasite, Trichinella, caused several disease outbreaks in Argentina that same year; one in Pehuajó resulted in over 160 infections, one in Canals in Córdoba Province resulted in over 230 cases, and in Bahía Blanca over 100 infections were reported in September. Most outbreaks were due to consumption of sausages or salami. Symptoms included fever, severe muscle pain, headache, ocular symptoms, diarrhoea and vomiting. Meanwhile, in spring 2018 the Japanese health ministry issued a warning about the parasite Anisakis in raw fish after several reports of infection in various areas of Japan, with acute epigastric pain being the main symptom. On a smaller scale, in Norway, sharing home-pressed apple juice with work colleagues in the autumn resulted in those colleagues reporting in sick one week later with violent diarrhoea due to infection with Cryptosporidium parvum. This snapshot illustrates the diversity of both symptoms and food vehicles associated with parasites. It also leads us once again to question why parasites are the neglected group among foodborne pathogens, and what their relative importance is. Some of these issues have previously been raised1 and problems specific to FBP that have been highlighted include their complexity, diagnosis and transmission attribution difficulties, and the lack of standard detection methods. We address some of these below, using examples of different parasites that also illustrate the importance and impact of these foodborne pathogens. Foodborne parasites: they're complicatedOne problem with parasites is, perhaps, their enormous diversity. Some are protozoa: minute, single-celled organisms that, like bacteria, can only be seen with a microscope; others (such as Trichinella) are worms, but are also microscopic; while some (like Anisakis) are over 1cm long. Some are even bigger: tapeworms (cestodes) can be several metres in length (see Figure 1), although their transmission stages (the part consumed with food to pass on the infection) are generally smaller. Most important, however, is the fact that FBP lifecycles vary tremendously. Some FBP transfer relatively simply from infected host to infected host by transmission stages excreted in faeces contaminating food. Others, however, may go through one or more intermediate hosts, and the infectious stage may end up in the flesh of a fish or animal, which is later ingested. Thus, to understand how food may contain an infective parasite stage requires knowledge about complex lifecycles. Excellent lifecycle illustrations are available (see, for example, www.cdc.gov/dpdx/az.html) – but it is questionable how often these are consulted by those in the food industry.  Figure 1: Single tapeworm (Taenia saginata) from a patient in Belgium in July 2018 (Photo credit, Idzi Potters, Institute of Tropical Medicine, Antwerp, Belgium. Confusingly, some parasites may have several possible routes of transmission to humans; different food types may be associated with transmission of different life stages of the same parasite, and the resulting symptoms may also differ. This is the case for some protozoan parasites, but is particularly important, although much neglected, for some tapeworms. For example, the pork tapeworm, Taenia solium, may infect humans when undercooked pork from an infected pig is consumed; cysticerci (tapeworm larvae) in the pork may result in a tapeworm developing in the intestine of the person. Although this worm may be several metres long and cause abdominal symptoms, the infection is considered relatively mild. However, Taenia solium eggs excreted in the faeces of an infected person may contaminate fresh produce, and if these are consumed then the cysticerci may develop in the unfortunate end consumer. Cysticerci in the central nervous system can cause serious symptoms and the infection may even be fatal. Indeed, Taenia solium is considered to be the most significant FBP globally, causing around 28,000 deaths.2,3 As illustrated, being vegetarian will not prevent infection by FBP parasites. Another example is Toxoplasma gondii. Calculations of disability adjusted life years (DALYs – a metric including both mortality and morbidity), showed that this foodborne pathogen has a high disease burden in the Netherlands,4 and elsewhere.5,6 As with other FBP, this burden is due to chronic, long-term sequelae. Transmission of Toxoplasma to humans can occur during various parasite stages, via such mediums as undercooked meat, fresh produce, or milk (see Figure 2).  Figure 2: Food transmission pathways for Toxoplasma gondii (Photo credit EFSA, 2018) Foodborne parasites and the slow disease movementOne reason why both consumers and food producers underestimate the likelihood and impact of FBP is due to the often-long period between ingestion of the parasite and onset of symptoms from the resultant infection. This means that pinpointing the meal from where the parasite originated – or, for some parasites, whether it was foodborne at all – is difficult. It is simply hard to make the connection between something that was eaten a while ago and being ill now. Generally, when people blame something they ate for feeling unwell, they point to what they consumed the day before. However, for FBP the period between infection and symptoms can sometimes be several days, but more usually weeks or months, and even years (see Table). Diagnosis may also be delayed, as the symptoms are often diverse and not pathognomonic, or because appropriate diagnostic tests are not requested. For example, opisthorchiasis, which is transmitted to people by ingestion of undercooked freshwater fish, is often asymptomatic, but may cause fever, abdominal pain, diarrhoea, fatigue, and diffuse myalgia. Furthermore, untreated chronic infection may result in the late development, after several years, of cholangiocarcinoma, a malignant cancer of the bile ducts with very poor prognosis. Thus, early diagnosis and appropriate treatment are essential. However, several outbreaks of opisthorchiasis in Italy between 2007 and 2011 indicate that many physicians in Europe are not really aware of this disease. This may result in people living undiagnosed and at risk of developing cholangiocarcinoma.1 In essence, we can expect foodborne parasitic diseases to be underdiagnosed, thus skewing our understanding of the prevalence of these pathogens. Our current awareness of the situation is probably only the tip of the iceberg. Foodborne parasites: we often don't look for them in foodIt may seem logical to look for FBP in food to ensure that it is safe for human consumption, and for some parasites (Trichinella, Taenia saginata cysticerci, Anisakis larvae) in some foods this is indeed the case – although the method sensitivity for some parasites can be low. However, for other FBP, methods to detect parasites in food are either lacking entirely or are impractical and expensive. Legislation that demands that food be checked for FBP is lacking for many FBP. For example, although Toxoplasma is a very important FBP, meat is not examined for this parasite.7 Furthermore, even when outbreaks do occur, implicated produce may not be checked – often due to the prolonged period between infection, symptoms and diagnosis meaning that the implicated food has already been consumed or discarded. This complicates proper source attribution, outbreak investigation, and tracking the origins and routes of infection. For example, an outbreak of cryptosporidiosis in the UK in 2012 involving hundreds of cases was associated with consumption of pre-cut mixed salad leaves, yet suspect foods were not analysed.8 Several reasons were given for this – the main one being that, from the first outbreak, over three weeks were estimated to have elapsed since exposure and, given the short shelf-life of salad, none of the contaminated product was likely to be available for testing. What have we learned and where are we going?Returning to the 2018 outbreaks of cyclosporiasis in USA, one in a recurring tide, it is clear that we still have considerable progress to make regarding FBP and their control. For some foods, salting, drying, freezing, or heating will reduce parasite infectivity, but data are scarce compared to those available for bacteria, and the means to assess parasite viability it is not always obvious.9 For minimally-processed foods or fresh produce, control options are few. This complicates addressing FBP in HACCP-based food safety control systems. With growing trends for eating minimally-processed food products, animals raised outdoors, and organic farming systems, the likelihood of our food containing FBP will likely increase. Fundamental questions remain about the epidemiology, survival and virulence of FBP. In addition, methods for detecting different parasites in various kinds of food, and removal or inactivation of FBP are not optimised. Answering these questions is fundamental, and initiatives to address them are appearing as knowledge gaps are recognised by relevant agencies. However, until both food suppliers and consumers become aware of FBP, finding answers to these questions will be a prolonged process. References
AcknowledgementsThis article was written as a collaboration within the framework of EURO-FBP, A European Network for Foodborne Parasites, COST Action FA1408. About the authorsLucy J. Robertson (Chair of COST Action FA1408) is a Professor in the Department of Food Safety and Infection Biology, Faculty of Veterinary Medicine, Norwegian University of Life Sciences, Adamstuen Campus. Joke WB van der Giessen (Leader of Workgroup 1 of COST Action FA1408) works at the Centre for Infectious Disease Control Netherlands, National Institute for Public Health and the Environment, Bilthoven, the Netherlands. Christian Klotz (Leader of Workgroup 2 of COST Action FA1408) works at the Unit for Mycotic and parasitic agents and mycobacteria, Robert Koch-Institute, Berlin, Germany. Peter Paulsen (Deputy Leader of Workgroup 3 of COST Action FA1408) works at the Institute for Meat Hygiene, University of Veterinary Medicine Vienna, Austria Chiara Trevisan (Deputy Leader of Workgroup 4 of COST Action FA1408) works at the Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.  |
| You are subscribed to email updates from "parasitic diseases examples" - Google News. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States | |
Comments
Post a Comment